Latest Breaking News On - Biosimilars be covered - Page 1 : comparemela.com

The launch of eight adalimumab biosimilars so far this year ended Humira s 20-year monopoly, but it s not clear yet if these discounted drugs will save patients money.

United statesSan franciscoMarta wosiCoherus yusimryMark fendrickFresenius kabi idacioIsaac sorensenMark cuban cost plus drug companyDrug administrationBrookings instituteCigna group express scriptsUniversity of michigan centerFresenius kabiBiosimilars be coveredCigna groupExpress scripts